Basiliximab Intravenous and Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Determining the interaction of Basiliximab Intravenous and Kisqali Femara Co-Pack 200 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: basiliximab
Brand name: Simulect
Synonyms: Basiliximab
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Basiliximab Intravenous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Basiliximab Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Basiliximab Intravenous-Kitabis Pak
- Basiliximab Intravenous-Kitabis Pak inhalation
- Basiliximab Intravenous-Klofensaid II
- Basiliximab Intravenous-Klonopin
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Bavencio
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Baxdela
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Baxdela (Delafloxacin Injection)
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Baxdela (Delafloxacin Tablets)
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Baxdela Intravenous
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Baycadron